Oral semaglutide: an OASIS from injectables.
Lancet
; 402(10403): 670-671, 2023 08 26.
Article
in En
| MEDLINE
| ID: mdl-37633662
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glucagon-Like Peptides
Limits:
Humans
Language:
En
Journal:
Lancet
Year:
2023
Document type:
Article
Country of publication:
United kingdom